AAAAAA

   
Results: 1-9 |
Results: 9
Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma
Authors: Motzer, RJ Rakhit, A Thompson, JA Nemunaitis, J Murphy, BA Ellerhorst, J Schwartz, LH Berg, WJ Bukowski, RM
Citation: Rj. Motzer et al., Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma, J INTERF CY, 21(4), 2001, pp. 257-263
Phase II evaluation of bryostatin-1 in metastatic melanoma
Authors: Bedikian, AY Plager, C Stewart, JR O'Brian, CA Herdman, SK Ross, M Papadopoulos, N Eton, O Ellerhorst, J Smith, T
Citation: Ay. Bedikian et al., Phase II evaluation of bryostatin-1 in metastatic melanoma, MELANOMA RE, 11(2), 2001, pp. 183-188
Whole brain irradiation for patients with metastatic melanoma: A review of87 cases
Authors: Ellerhorst, J Strom, E Nardone, E McCutcheon, I
Citation: J. Ellerhorst et al., Whole brain irradiation for patients with metastatic melanoma: A review of87 cases, INT J RAD O, 49(1), 2001, pp. 93-97
Down-regulated melanoma differentiation associated gene (MDA-7) expressionin human melanomas
Authors: Ekmekcioglu, S Ellerhorst, J Mhashilkar, AM Sahin, AA Read, CM Prieto, VG Chada, S Grimm, EA
Citation: S. Ekmekcioglu et al., Down-regulated melanoma differentiation associated gene (MDA-7) expressionin human melanomas, INT J CANC, 94(1), 2001, pp. 54-59
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival
Authors: Ekmekcioglu, S Ellerhorst, J Smid, CM Prieto, VG Munsell, M Buzaid, AC Grimm, EA
Citation: S. Ekmekcioglu et al., Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival, CLIN CANC R, 6(12), 2000, pp. 4768-4775
A phase II evaluation of Bexarotene (Targretin (R)) capsules in patients with metastatic melanoma
Authors: Bedikian, AY Plager, C Papadopoulos, N Ellerhorst, J Smith, T Benjamin, RS
Citation: Ay. Bedikian et al., A phase II evaluation of Bexarotene (Targretin (R)) capsules in patients with metastatic melanoma, ONCOL REP, 7(4), 2000, pp. 883-886
Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype
Authors: Ellerhorst, J Nguyen, T Cooper, DNW Lotan, D Lotan, R
Citation: J. Ellerhorst et al., Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype, INT J ONCOL, 14(2), 1999, pp. 217-224
Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1
Authors: Ellerhorst, J Nguyen, T Cooper, DNW Estrov, Y Lotan, D Lotan, R
Citation: J. Ellerhorst et al., Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1, INT J ONCOL, 14(2), 1999, pp. 225-232
Galectin-1 and galectin-3 expression in human prostate tissue and prostatecancer
Authors: Ellerhorst, J Troncoso, P Xu, XC Lee, J Lotan, R
Citation: J. Ellerhorst et al., Galectin-1 and galectin-3 expression in human prostate tissue and prostatecancer, UROL RES, 27(5), 1999, pp. 362-367
Risultati: 1-9 |